Doctors Research Group
Stage
Debt | AliveTotal Raised
$8.14MLast Raised
$440K | 8 yrs agoAbout Doctors Research Group
Doctors Research Group focuses on producing and marketing medical products. Currently, they are focusing on the development of a new type of bone cement or bone glue called Kryptonite.
Doctors Research Group Patents
Doctors Research Group has filed 4 patents.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
10/7/2009 | 12/25/2012 | Surgical removal procedures, Surgical procedures and techniques, Digestive system surgery, Orthopedic surgical procedures, Surgery | Grant |
Application Date | 10/7/2009 |
---|---|
Grant Date | 12/25/2012 |
Title | |
Related Topics | Surgical removal procedures, Surgical procedures and techniques, Digestive system surgery, Orthopedic surgical procedures, Surgery |
Status | Grant |
Doctors Research Group Frequently Asked Questions (FAQ)
Where is Doctors Research Group's headquarters?
Doctors Research Group's headquarters is located at 35 South Ridge Ct, Ridgefield.
What is Doctors Research Group's latest funding round?
Doctors Research Group's latest funding round is Debt.
How much did Doctors Research Group raise?
Doctors Research Group raised a total of $8.14M.
Who are the investors of Doctors Research Group?
Investors of Doctors Research Group include Univ of Connecticut Technology Incubation Program.
Who are Doctors Research Group's competitors?
Competitors of Doctors Research Group include Noraker, Wright Medical Group, Expanding Orthopedics, Small Bone Innovations, Synthes and 12 more.
Compare Doctors Research Group to Competitors

Design, manufacturing and marketing of long term implantable medical devices dedicated to bone reconstruction for applications in orthopedic, spinal, dental and skull-maxillo-facial surgeries.The company's main aim is to conceive bioresorbable implants helping surgeons to improve patients' welfare.
Connective Orthopaedics is a medical device company focused on the repair of soft tissue injuries.
Tissue Regeneration Systems (TRS) is commercializing a skeletal reconstruction and bone reconstruction technology for the fabrication of bioresorbable implants. These implants fully replace themselves with natural bone over time, leaving no residual implanted device; moreover, although the micro-architecture of these implants is porous for the facilitation of bone integration, they can nonetheless bear load and are strong enough to support function without the need for reinforcement from metal plates. Such structural integrity enables them to be used as an alternative to harvested, autologous bone that is fixed with metallic plates for complex skeletal reconstruction. TRS implants are also integrated with an osteoconductive coating that enhances bone regeneration and proliferation; powerful orthobiologics and bone-growing autologous cells will readily bind to this coating, allowing for a controlled biologic release to further accelerate bone formation.

Autocam Medical manufactures high-precision components, instruments, implants and handpieces for a variety of medical applications. Some of the company's products include implants, instruments, handpieces, and components.
Biorthex is an orthopedic device manufacturer that develops manufactures and markets innovative spinal interbody fusion devices and instruments for the treatment of degenerative conditions of the human spine
Biomimedica is developing earlier intervention solutions to treat osteoarthritis that will allow patients to maintain a pain-free, active lifestyle.